Cargando…

Human cardiac fibroblasts express B-type natriuretic peptide: fluvastatin ameliorates its up-regulation by interleukin-1α, tumour necrosis factor-α and transforming growth factor-β

B-type natriuretic peptide (BNP) is a cardiac hormone, which plays a major role in body fluid and cardiovascular homeostasis. Produced by cardiac ventricles, its expression is highly regulated by various mediators. Canine cardiac fibroblasts have been identified as a source of BNP. Cardiac fibroblas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jarai, Rudolf, Kaun, Christoph, Weiss, Thomas W, Speidl, Walter S, Rychli, Kathrin, Maurer, Gerald, Huber, Kurt, Wojta, Johann
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2009
Materias:	Short Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4515057/ https://www.ncbi.nlm.nih.gov/pubmed/19228263 http://dx.doi.org/10.1111/j.1582-4934.2009.00704.x

Ejemplares similares

An increase of interleukin-33 serum levels after coronary stent implantation is associated with coronary in-stent restenosis
por: Demyanets, Svitlana, et al.
Publicado: (2014)

Soluble ST2 and Interleukin-33 Levels in Coronary Artery Disease: Relation to Disease Activity and Adverse Outcome
por: Demyanets, Svitlana, et al.
Publicado: (2014)

The anti-angiogenic factor PEDF is present in the human heart and is regulated by anoxia in cardiac myocytes and fibroblasts
por: Rychli, Kathrin, et al.
Publicado: (2010)

The adipokine vaspin is associated with decreased coronary in-stent restenosis in vivo and inhibits migration of human coronary smooth muscle cells in vitro
por: Kastl, Stefan P., et al.
Publicado: (2020)

The pro-inflammatory marker soluble suppression of tumorigenicity-2 (ST2) is reduced especially in diabetic morbidly obese patients undergoing bariatric surgery
por: Demyanets, Svitlana, et al.
Publicado: (2020)

Components of the interleukin-33/ST2 system are differentially expressed and regulated in human cardiac cells and in cells of the cardiac vasculature
por: Demyanets, Svitlana, et al.
Publicado: (2013)

Copeptin Predicts Mortality in Critically Ill Patients
por: Krychtiuk, Konstantin A., et al.
Publicado: (2017)

Cardioprotective cytokine interleukin‐33 is up‐regulated by statins in human cardiac tissue
por: Pentz, Richard, et al.
Publicado: (2018)

Interleukin-15 and Tumor Necrosis Factor-α in Iraqi Patients with Alopecia Areata
por: Kamil, Zainab A., et al.
Publicado: (2023)

Interleukin-6, tumour necrosis factor α and interleukin-1β in patients with renal cell carcinoma
por: Yoshida, N, et al.
Publicado: (2002)

Interleukin‐4 receptor alpha signaling regulates monocyte homeostasis
por: Haider, Patrick, et al.
Publicado: (2022)

Tissue factor is induced by interleukin-33 in human endothelial cells: a new link between coagulation and inflammation
por: Stojkovic, Stefan, et al.
Publicado: (2016)

Influence of tumor necrosis factor α in rheumatoid arthritis
por: Kulp, Werner, et al.
Publicado: (2005)

Alternative activation of human macrophages enhances tissue factor expression and production of extracellular vesicles
por: Hohensinner, Philipp J., et al.
Publicado: (2020)

Critical Roles for Interleukin 1 and Tumor Necrosis Factor α in Antibody-induced Arthritis
por: Ji, Hong, et al.
Publicado: (2002)

Tumor Necrosis Factor α and Interleukin 1β Enhance the Cortisone/Cortisol Shuttle
por: Escher, Geneviève, et al.
Publicado: (1997)

Mechanisms of tumor necrosis factor-α-induced interleukin-6 synthesis in glioma cells
por: Tanabe, Kumiko, et al.
Publicado: (2010)

Salivary levels of interleukin-6 and tumor necrosis factor-α in patients undergoing hemodialysis
por: Khozeymeh, Faezeh, et al.
Publicado: (2016)

Expression of Tumor Necrosis Factor‐α and Interleukin‐6 in Oral Squamous Cell Carcinoma
por: Nakano, Yasuko, et al.
Publicado: (1999)

Serum Levels of Tumor Necrosis Factor-α and Interleukins in Children with Congenital Heart Disease
por: Noori, Noor Mohammand, et al.
Publicado: (2017)

Interleukin-6 and tumor necrosis factor-α levels in tear film of Keratoconus patients
por: Peyman, Alireza, et al.
Publicado: (2021)

Changes in Interleukin-1β, Tumor Necrosis Factor-α, and Interleukin-10 Cytokines in Older People with Periodontitis
por: Sumbayak, Ines Augustina, et al.
Publicado: (2023)

Neutrophil Extracellular Trap Degradation by Differently Polarized Macrophage Subsets
por: Haider, Patrick, et al.
Publicado: (2020)

Effects of Nicorandil on Inflammation, Apoptosis and Atherosclerotic Plaque Progression
por: Lenz, Max, et al.
Publicado: (2021)

Mechanisms of tumor necrosis factor-α and interleukin-6 induction during human liver transplantation
por: Hamilton, Gerhard, et al.
Publicado: (1993)

Racial differences in tumor necrosis factor-α-induced endothelial microparticles and interleukin-6 production
por: Brown, Michael D, et al.
Publicado: (2011)

Immunohistochemical staining of tumor necrosis factor-α and interleukin-10 in benign and malignant ovarian neoplasms
por: JAMMAL, MILLENA PRATA, et al.
Publicado: (2015)

Tumor Necrosis Factor‐α and Interleukin‐6 Concentrations in Cerebrospinal Fluid of Dogs After Seizures
por: Merbl, Y., et al.
Publicado: (2014)

Tumor necrosis factor-α blockade ameliorates diabetic nephropathy in rats
por: Cheng, Dongsheng, et al.
Publicado: (2019)

Salivary interleukin 6, interleukin 8, interleukin 17A, and tumour necrosis factor α levels in patients with periodontitis and rheumatoid arthritis
por: Kaczyński, Tomasz, et al.
Publicado: (2019)

A Dual Target-directed Agent against Interleukin-6 Receptor and Tumor Necrosis Factor α ameliorates experimental arthritis
por: Kim, Youngkyun, et al.
Publicado: (2016)

Enantiospecific Pharmacogenomics of Fluvastatin
por: Hirvensalo, Päivi, et al.
Publicado: (2019)

Pretreatment serum interleukin‐1β, interleukin‐6, and tumor necrosis factor‐α levels predict the progression of colorectal cancer
por: Chang, Pei‐Hung, et al.
Publicado: (2016)

Tumour necrosis factor-α in nasal allergy
por: Hisamatsu, K., et al.
Publicado: (1995)

The Effects of Interleukin-1β in Tumor Necrosis Factor-α-Induced Acute Pulmonary Inflammation in Mice
por: Saperstein, Sara, et al.
Publicado: (2009)

Interleukin-1β and tumor necrosis factor-α: reliable targets for protective therapies in Parkinson’s Disease?
por: Leal, María C., et al.
Publicado: (2013)

Circulating interleukin-8 and tumor necrosis factor-α are associated with hot flashes in healthy postmenopausal women
por: Huang, Wan-Yu, et al.
Publicado: (2017)

Release kinetics of tumor necrosis factor-α and interleukin-1 receptor antagonist in the equine whole blood
por: Rütten, Simon, et al.
Publicado: (2016)

Amelioration of cancer cachexia with preemptive administration of tumor necrosis factor-α blocker
por: Kang, Eun A, et al.
Publicado: (2022)

Mesenchymal stem cell (MSC) homing to kidneys is suppressed by inhibiting interleukin 1-α, tumor necrosis factor-α, or cyclooxygenase-2 signaling
por: Burks, Scott, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_n4dltj1jp2bdk3tguniprrm4vi